Each additional hour of cold ischemia time significantly increases the risk of graft failure and mortality following renal transplantation

Kidney International

Volumn 87, Issue 2, 2015, Pages 343-349

  Debout, Agnes ^a   Foucher, Yohann ^a,b   Trébern Launay, Katy ^a,b   Legendre, Christophe ^c,d   Kreis, Henri ^c,d   Mourad, Georges ^e   Garrigue, Valérie ^e   Morelon, Emmanuel ^f   Buron, Fanny ^f   Rostaing, Lionel ^g,h   Kamar, Nassim ^g,h   Kessler, Michèle ⁱ   Ladrière, Marc ⁱ   Poignas, Alexandra ^j   Blidi, Amina ^b   Soulillou, Jean Paul ^a   Giral, Magali ^a,j   Dantan, Etienne ^b  

^a UNIVERSITÉ DE NANTES   (France)

^b Universite de Nantes   (France)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

^e UNIV MONTPELLIER   (France)

^f EDOUARD HERRIOT HOSPITAL   (France)

^g CHU RANGUEIL   (France)

^h UNIVERSITÉ DE TOULOUSE   (France)

ⁱ CHU NANCY BRABOIS   (France)

^j Centre d Investigation Clinique biothérapie   (France)

more..

Author keywords

cold ischemia time; graft survival; kidney transplantation; patient survival

Indexed keywords

ADULT; ARTICLE; COLD ISCHEMIA; FEMALE; FOLLOW UP; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT SURVIVAL; HAZARD RATIO; HUMAN; KIDNEY DONOR; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; RISK ASSESSMENT; TREATMENT OUTCOME; ADVERSE EFFECTS; AGED; COHORT ANALYSIS; EPIDEMIOLOGY; FRANCE; MIDDLE AGED; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RISK FACTOR; SURVIVAL ANALYSIS; TIME FACTOR; TREATMENT FAILURE;

ADULT; AGED; COHORT STUDIES; COLD ISCHEMIA; FEMALE; FRANCE; GRAFT SURVIVAL; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT FAILURE;

EID: 84922136914     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2014.304     Document Type: Article

References (36)

1. Gonwa T, Johnson C, Ahsan N et al. Randomized trial of tacrolimus+ mycophenolate mofetil or azathioprine versus cyclosporine+ mycophenolate mofetil after cadaveric kidney transplantation: results at three years. [Miscellaneous Article]. Transplant 2003; 75: 2048-2053.
2. Knight SR, Russell NK, Barcena L et al. Mycophenolate mofetil decreases acute rejection and may improve graft survival in renal transplant recipients when compared with azathioprine: a systematic review. Transplantation 2009; 87: 785-794.
3. Ekberg H, Bernasconi C, Tedesco-Silva H et al. Calcineurin inhibitor minimization in the Symphony study: observational results 3 years after transplantation. Am J Transplant 2009; 9: 1876-1885.
4. Metzger RA, Delmonico FL, Feng S et al. Expanded criteria donors for kidney transplantation. Am J Transplant 2003; 3(Suppl 4): 114-125.
5. Yarlagadda SG, Klein CL, Jani A. Long-Term renal outcomes after delayed graft function. Adv Chronic Kidney Dis 2008; 15: 248-256.
6. Jayaram D, Kommareddi M, Sung RS et al. Delayed graft function requiring more than one-Time dialysis treatment is associated with inferior clinical outcomes. Clin Transplant 2012; 26: E536-E543.
7. Giral-Classe M, Hourmant M, Cantarovich D et al. Delayed graft function of more than six days strongly decreases long-Term survival of transplanted kidneys. Kidney Int 1998; 54: 972-978.
8. Tapiawala SN, Tinckam KJ, Cardella CJ et al. Delayed graft function and the risk for death with a functioning graft. J Am Soc Nephrol 2010; 21: 153-161.
9. Yarlagadda SG, Coca SG, Formica RN et al. Association between delayed graft function and allograft and patient survival: a systematic review and meta-Analysis. Nephrol Dial Transplant 2009; 24: 1039-1047.
10. Perico N, Cattaneo D, Sayegh MH et al. Delayed graft function in kidney transplantation. Lancet 2004; 364: 1814-1827.
11. Irish WD, Ilsley JN, Schnitzler MA et al. A risk prediction model for delayed graft function in the current era of deceased donor renal transplantation. Am J Transplant 2010; 10: 2279-2286.
12. Opelz G, Dö hler B. Multicenter analysis of kidney preservation. Transplantation 2007; 83: 247-253.
13. Chapal M, Le Borgne F, Legendre C et al. The DGFS: a useful scoring system for the prediction and management of delayed graft function following kidney transplantation from heart beating deceased donors. Kidney Int (e-pub ahead of print, 4 June 2014; doi:10.1038/ki.2014.188).
14. Mikhalski D, Wissing KM, Ghisdal L et al. Cold ischemia is a major determinant of acute rejection and renal graft survival in the modern era of immunosuppression. Transplantation 2008; 85: S3-S9.
15. Kayler LK, Srinivas TR, Schold JD. Influence of CIT-induced DGF on kidney transplant outcomes. Am J Transplant 2011; 11: 2657-2664.
16. Kayler LK, Magliocca J, Zendejas I et al. Impact of cold ischemia time on graft survival among ECD transplant recipients: a paired kidney analysis. Am J Transplant 2011; 11: 2647-2656.
17. Johnson RJ, Fuggle SV, O'Neill J et al. Factors influencing outcome after deceased heart beating donor kidney transplantation in the United Kingdom: an evidence base for a new national kidney allocation policy. Transplantation 2010; 89: 379-386.
18. Summers DM, Johnson RJ, Hudson A et al. Effect of donor age and cold storage time on outcome in recipients of kidneys donated after circulatory death in the UK: a cohort study. Lancet 2013; 381: 727-734.
19. Ojo AO, Wolfe RA, Held PJ et al. Delayed graft function: risk factors and implications for renal allograft survival. Transplant 1997; 63: 968-974.
20. Salahudeen AK, Haider N, May W. Cold ischemia and the reduced longterm survival of cadaveric renal allografts. Kidney Int 2004; 65: 713-718.
21. Quiroga I, McShane P, Koo DDH et al. Major effects of delayed graft function and cold ischaemia time on renal allograft survival. Nephrol Dial Transplant 2006; 21: 1689-1696.
22. Morris PJ, Johnson RJ, Fuggle SV et al. Analysis of factors that affect outcome of primary cadaveric renal transplantation in the UK. Lancet 1999; 354: 1147-1152.
23. Van der Vliet JA, Warlé MC, Cheung CLS et al. Influence of prolonged cold ischemia in renal transplantation. Clin Transplant 2011; 25: E612-E616.
24. Hernández D, Estupinán S, Pérez G et al. Impact of cold ischemia time on renal allograft outcome using kidneys from young donors. Transpl Int 2008; 21: 955-962.
25. Neumayer HH, Kunzendorf U, Schreiber M. Protective effects of calcium antagonists in human renal transplantation. Kidney Int Suppl 1992; 36: S87-S93.
26. Dawidson IJ, Sandor ZF, Coorpender L et al. Intraoperative albumin administration affects the outcome of cadaver renal transplantation. Transplantation 1992; 53: 774-782.
27. Powell JT, Tsapepas DS, Martin ST et al. Managing renal transplant ischemia reperfusion injury: novel therapies in the pipeline. Clin Transplant 2013; 27: 484-491.
28. Moers C, Kornmann NS, Leuvenink HG et al. The influence of deceased donor age and old-for-old allocation on kidney transplant outcome. Transplantation 2009; 88: 542-552.
29. Jager KJ, Zoccali C, Macleod A et al. Confounding: what it is and how to deal with it. Kidney Int 2008; 73: 256-260.
30. Butala NM, Reese PP, Doshi MD et al. Is delayed graft function causally associated with long-Term outcomes after kidney transplantation? Instrumental variable analysis. Transplantation 2013; 95: 1008-1014.
31. Ladriere M, Foucher Y, Legendre C et al. The Western Europe cohort of kidney transplant recipients-The DIVAT Network. Clin Transplant 2010; 460-461.
32. Tripepi G, Jager KJ, Dekker FW et al. Testing for causality and prognosis: etiological and prognostic models. Kidney Int 2008; 74: 1512-1515.
33. Hougaard P. Shared frailty models. In: Analysis of Multivariate Survival Data. Springer: New York, 2000, pp 215-262.
34. Grambsch P, Therneau T. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika 1994; 81: 515-526.
35. Therneau TM, Grambsch PM, Fleming TR. Martingale-based residuals for survival models. Biometrika 1990; 77: 147-160.
36. R Development Core Team. R: A Language and Environment for Statistical Computing. Computing RF for S, (ed).: Vienna, Austria, 2010.